UNII X573657P6P
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
UNII Information
- Unique Ingredient Identifier: X573657P6P
- The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
- Preferred Substance Name: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
- The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
- SMILES: C6H9N3O2.ClH.H2O
- The Simplified Molecular Input Line Entry System or SMILES is a format used to represent and describe the molecular structure of a substance or ingredient. SMILES uses a series of alphanumeric characters to represent the atoms and bonds in a molecule in conjunction with other symbols and operators to indicate the arrangement and connectivity of the atoms.
- Registry Number: 5934-29-2
- The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
- NCI Thesaurus Concept Code: C87334
- The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
- UNII to RxNorm Crosswalk: 1305609 (RXCUI)
- The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
- PubChem Compound ID: 165377
- The PubChem Compound ID is a unique identifier for a specific substance or ingredient in the PubChem database which is the largest collection of freely accessible chemical information by the National Center for Biotechnology Information. The PubChem database is a resource for drug discovery, development, chemical research, and other applications.
- ITIS TSN: DTXSID00208089
- The Taxonomic Serial Number is a unique identifier for a specific species of organism in the Integrated Taxonomic Information System. The ITIS is a comprehensive database of taxonomic information on plants, animals, fungi, and microbes, maintained by a partnership of several US government agencies.
- Ingredient Type: CMXXUDSWGMGYLZ-XRIGFGBMSA-N
- Substance Type: INGREDIENT SUBSTANCE
- The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.
UNII Synonyms and Mappings
The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.
- HISTIDINE HYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
- HISTIDINE HYDROCHLORIDE MONOHYDRATE [EP MONOGRAPH] - Common Name
- HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
- HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE, (-)- - Systematic Name (chemical and taxonomic names)
- HISTIDINE, L-, HYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
- HISTIDINE, L-, MONOHYDROCHLORIDE MONOHYDRATE - Common Name
- L-HISTIDINE HYDROCHLORIDE HYDRATE [JAN] - Common Name
- L-HISTIDINE MONOHYDROCHLORIDE [FCC] - Common Name
- L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE - Systematic Name (chemical and taxonomic names)
- L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE [USP-RS] - Common Name
- L-HISTIDINE, HYDROCHLORIDE, HYDRATE (1:1:1) - Systematic Name (chemical and taxonomic names)
UNII Resources
- Common Chemistry
- CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
- Inxight Drugs
- The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
- DailyMed Regulated Products
- The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
- NCATS GSRS Full Record
- The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
- NCI Thesaurus
- NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.
- PubChem
- The PubChem database by the National Library of Medicine includes the chemical structures of small organic molecules and information on their biological activities.
UNII Crossover to NDC Codes
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0002-1436 | Proprietary Name: Emgality | Galcanezumab-gnlm | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-1436 | Proprietary Name: | Galcanezumab-gnlm | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-2377 | Proprietary Name: | Galcanezumab-gnlm | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-2377 | Proprietary Name: Emgality | Galcanezumab-gnlm | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-3115 | Proprietary Name: Emgality | Galcanezumab-gnlm | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-3115 | Proprietary Name: | Galcanezumab-gnlm | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-7589 | Proprietary Name: Bebtelovimab | Bebtelovimab | Injection, Solution | Intravenous | Eli Lilly And Company | ACTIVE | |
0002-7910 | Proprietary Name: Bamlanivimab | Bamlanivimab | Injection, Solution | Intravenous | Eli Lilly And Company | ACTIVE | |
0002-7910 | Proprietary Name: | Bamlanivimab | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-7950 | Proprietary Name: | Etesevimab | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-7950 | Proprietary Name: Etesevimab | Etesevimab | Injection, Solution | Intravenous | Eli Lilly And Company | ACTIVE | |
0003-7125 | Proprietary Name: Opdualag | Nivolumab And Relatlimab-rmbw | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | |
0024-0654 | Proprietary Name: Sarclisa | Isatuximab | Injection, Solution, Concentrate | Intravenous | Sanof-aventis U.s. Llc | ACTIVE | |
0024-0656 | Proprietary Name: Sarclisa | Isatuximab | Injection, Solution, Concentrate | Intravenous | Sanof-aventis U.s. Llc | ACTIVE | |
0069-0238 | Proprietary Name: Ruxience | Rituximab-pvvr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0249 | Proprietary Name: Ruxience | Rituximab-pvvr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0305 | Proprietary Name: Trazimera | Trastuzumab-qyyp | Kit | Pfizer Laboratories Div Pfizer Inc | ACTIVE | ||
0069-2522 | Proprietary Name: Elrexfio | Elranatamab-bcmm | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-4494 | Proprietary Name: Elrexfio | Elranatamab-bcmm | Injection, Solution | Subcutaneous | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0078-0639 | Proprietary Name: Cosentyx | Secukinumab | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
0078-1056 | Proprietary Name: Cosentyx | Secukinumab | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | ACTIVE | |
0310-3040 | Proprietary Name: Saphnelo | Anifrolumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4500 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4505 | Proprietary Name: Imjudo | Tremelimumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4535 | Proprietary Name: Imjudo | Tremelimumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
0310-4611 | Proprietary Name: Imfinzi | Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
49281-574 | Proprietary Name: Beyfortus | Nirsevimab | Injection | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
49281-575 | Proprietary Name: Beyfortus | Nirsevimab | Injection | Intramuscular | Sanofi Pasteur Inc. | ACTIVE | |
50090-6704 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6705 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6706 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6707 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50242-040 | Proprietary Name: Xolair | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-070 | Proprietary Name: Gazyva | Obinutuzumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | |
50242-077 | Proprietary Name: Herceptin Hylecta | Trastuzumab And Hyaluronidase-oysk | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-108 | Proprietary Name: Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-109 | Proprietary Name: Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-125 | Proprietary Name: Columvi | Glofitamab | Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | |
50242-127 | Proprietary Name: Columvi | Glofitamab | Concentrate | Intravenous | Genentech, Inc. | ACTIVE | |
50242-132 | Proprietary Name: Herceptin | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | |
50242-138 | Proprietary Name: Actemra | Tocilizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-214 | Proprietary Name: Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
50242-215 | Proprietary Name: Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | |
51144-003 | Proprietary Name: Tivdak | Tisotumab Vedotin | Injection, Powder, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
51144-020 | Proprietary Name: Padcev EJFV | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
51144-030 | Proprietary Name: Padcev EJFV | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Seagen Inc. | ACTIVE | |
55513-132 | Proprietary Name: Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Amgen Inc | ACTIVE | |
57894-054 | Proprietary Name: Stelara | Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-060 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-061 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-070 | Proprietary Name: Simponi | Golimumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-071 | Proprietary Name: Simponi | Golimumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-350 | Proprietary Name: Simponi Aria | Golimumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-501 | Proprietary Name: Rybrevant | Amivantamab | Injection | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-503 | Proprietary Name: Darzalex Faspro | Daratumumab And Hyaluronidase-fihj (human Recombinant) | Injection | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-640 | Proprietary Name: Tremfya | Guselkumab | Injection | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
58468-0426 | Proprietary Name: Nexviazyme ngpt | Avalglucosidase Alfa | Injection, Powder, Lyophilized, For Solution | Intravenous | Genzyme Corporation | ACTIVE | |
61755-008 | Proprietary Name: Libtayo | Cemiplimab-rwlc | Injection | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-010 | Proprietary Name: Evkeeza | Evinacumab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-013 | Proprietary Name: Evkeeza | Evinacumab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-014 | Proprietary Name: Veopoz | Pozelimab | Injection, Solution | Intravenous; Subcutaneous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-018 | Proprietary Name: Inmazeb | Atoltivimab, Maftivimab, And Odesivimab-ebgn | Injection, Solution | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-024 | Proprietary Name: Casirivimab | Casirivimab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-025 | Proprietary Name: Imdevimab | Imdevimab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-026 | Proprietary Name: Casirivimab | Casirivimab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-027 | Proprietary Name: Imdevimab | Imdevimab | Injection, Solution, Concentrate | Intravenous | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
61755-050 | Proprietary Name: Eylea Hd | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc | ACTIVE | |
61755-051 | Proprietary Name: Eylea Hd | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc | ACTIVE | |
62856-212 | Proprietary Name: Leqembi | Lecanemab | Injection, Solution | Intravenous | Eisai Inc. | ACTIVE | |
62856-215 | Proprietary Name: Leqembi | Lecanemab | Injection, Solution | Intravenous | Eisai Inc. | ACTIVE | |
63539-252 | Proprietary Name: Elrexfio | Elranatamab-bcmm | Injection, Solution | Subcutaneous | U.s. Pharmaceuticals | ACTIVE | |
64406-101 | Proprietary Name: Aduhelm | Aducanumab | Injection, Solution | Intravenous | Biogen Inc. | ACTIVE | |
64406-102 | Proprietary Name: Aduhelm | Aducanumab | Injection, Solution | Intravenous | Biogen Inc. | ACTIVE | |
65597-406 | Proprietary Name: Enhertu | Fam-trastuzumab Deruxtecan-nxki | Injection, Powder, Lyophilized, For Solution | Intravenous | Daiichi Sankyo Inc. | ACTIVE | |
66658-501 | Proprietary Name: Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | ACTIVE | |
66658-505 | Proprietary Name: Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | ACTIVE | |
67386-130 | Proprietary Name: Vyepti | Eptinezumab-jjmr | Injection | Intravenous | Lundbeck Pharmaceuticals Llc | ACTIVE | |
70114-210 | Proprietary Name: Yusimry | Adalimumab-aqvh | Injection, Solution | Subcutaneous | Coherus Biosciences Inc | ACTIVE | |
70114-220 | Proprietary Name: Yusimry | Adalimumab-aqvh | Injection, Solution | Subcutaneous | Coherus Biosciences Inc | ACTIVE | |
70114-440 | Proprietary Name: Cimerli | Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE | |
70114-441 | Proprietary Name: Cimerli | Ranibizumab-eqrn | Injection, Solution | Intravitreal | Coherus Biosciences Inc | ACTIVE | |
72677-551 | Proprietary Name: Uplizna | Inebilizumab | Injection | Intravenous | Viela Bio, Inc. | ACTIVE | |
73539-001 | Proprietary Name: Lantidra | Donislecel | Solution | Intravascular | Celltrans Inc. | ACTIVE | |
75987-130 | Proprietary Name: Tepezza | Teprotumumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
75987-150 | Proprietary Name: Uplizna | Inebilizumab | Injection | Intravenous | Horizon Therapeutics Usa, Inc. | ACTIVE | |
78206-147 | Proprietary Name: Ontruzant | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Organon Llc | ACTIVE | |
78206-148 | Proprietary Name: Ontruzant | Ontruzant | Kit | Intravenous | Organon Llc | ACTIVE | |
78206-183 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE | |
78206-184 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE | |
78206-185 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE | |
78206-186 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE | |
78206-187 | Proprietary Name: Hadlima | Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |